NCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
Clinical Trials
89 trialsNCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07405385 2026-02-12
CARE-BREAST
University of Castilla-La Mancha
Phase NA Not yet recruiting
NCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
NCT06332131 2026-02-09
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Abramson Cancer Center at Penn Medicine
Enrolling by invitation
NCT06443645 2026-02-04
SCARA-B
Centre Paul Strauss
Recruiting
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07299812 2025-12-23
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT02696707 2025-12-18
OTT 15-05
Ottawa Hospital Research Institute
Phase 4 Completed
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT04023110 2025-10-09
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT05036252 2025-09-30
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT02772367 2025-07-16
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Recruiting
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT06310330 2025-06-06
TRUST-ACE
Norwegian University of Science and Technology
Phase NA Recruiting
NCT06986291 2025-05-29
CorTox
Technische Universität Dresden
Phase NA Not yet recruiting
NCT06930521 2025-04-16
JUSTIFY
Women's College Hospital
Phase NA Not yet recruiting
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT06881940 2025-03-18
CARPTOX-BC
Instituto Nacional de Cardiologia Ignacio Chavez
Phase NA Not yet recruiting
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT05403736 2025-02-06
CARMA
Cedars-Sinai Medical Center
Phase NA Completed
NCT06622954 2024-10-02
PROTECT-COR
Erasmus Medical Center
Phase NA Recruiting
NCT06595316 2024-09-19
Exercise for Ameliorating Chemotherapy Cardiotoxicity
University of Hull
Phase NA Not yet recruiting
NCT03748550 2024-08-21
EXACT2
Nova Scotia Health Authority
Phase NA Active not recruiting
NCT05851053 2024-05-29
BLOC-II
University Medical Center Groningen
Recruiting
NCT05467111 2024-04-11
CardioProtEx
Technical University of Madrid
Phase NA Recruiting
NCT04896242 2024-04-04
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Pontificia Universidad Catolica de Chile
Completed
NCT06341842 2024-04-02
PROTECT
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2 Unknown
NCT06282796 2024-02-28
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
First Hospital of China Medical University
Recruiting
NCT02881203 2023-07-27
BRAVEHeart
University of Sydney
Phase NA Completed
NCT05921279 2023-07-25
UCARE
National University of Ireland, Galway, Ireland
Recruiting
NCT05960214 2023-07-25
AQUA
Istanbul University
Completed
NCT05927246 2023-07-03
RADAF
Istanbul University
Completed
NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
NCT01719562 2023-05-19
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
Phase NA Completed
NCT03964142 2023-05-12
ONCORE
Hospital Clinico Universitario de Santiago
Phase NA Completed
NCT05732051 2023-03-17
NARNIA
University Hospital, Akershus
Phase 2 Recruiting
NCT03850171 2023-02-27
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
Phase NA Terminated
NCT05728632 2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3 Unknown
NCT05733026 2023-02-17
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
Ain Shams University
Unknown